The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus

Clinical trial NCT04633733 · UNKNOWN

Trial details

NCT number: NCT04633733
Sponsor: Hanlim Pharm. Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Volunteers

Start date: 2020-08-22
Primary completion: 2020-09-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.